We have shown early upregulation of the rate-limiting amyloidogenic enzyme β-secretase-1 (BACE1) inherent with axon terminal sprouting and dystrophy in transgenic AD mouse models, pointing to a leading role for pathological axonal sprouting in plaque development [29],[30],[31]. The gene discussed is BACE1; the disease is Alzheimer disease.